Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dacomitinib vs Placebo in Advanced NSCLC (BR26)
NCT01000025Phase 3Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Dec 2009
- Primary completion
- Jan 2014
- Countries
- 12
01
Overview
A Phase 3 trial of dacomitinib in non-small cell lung cancer (NSCLC), sponsored by Canadian Cancer Trials Group. Started Dec 2009; status: completed.
02
Drugs
dacomitinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01000025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01000025.